AB Science S.A. (the "Company” or "AB Science ,” Euronext - FR0010557264 - AB) today announces the successful settlement and delivery of the securities issued as part of its capital increases ...
AB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM, SUSPENDING SOME NON-PRIORITY CLINICAL TRIALS TO FOCUS ON TWO CLINICAL PROGRAMS Paris, July 10, 2026, 6pm CET AB Science SA (Euronext - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results